CPETC after exposure to TFA
Trifluoroacetic acid (TFA) (100 μL) was added to 2-cyanoprop-2-yl ethyl trithiocarbonate (CPETC) (20.5 mg, 0.1 mmol). The reaction mixture was stirred at room temperature. Aliquots were removed at 0, 5 and 30 minutes, and the reaction was monitored by 1 H NMR analysis in chloroform.
The peaks of CPETC (3.35, 1.88, and 1.35 ppm) were monitored upon the addition of TFA (Fig. S4 ). After 5 minutes, additional peaks appeared, indicating the formation of products likely due to degradation of CPETC.
After 30 minutes, the multiplets around 3.3 and 1.34 ppm remain, while the singlet at 1.88 ppm has disappeared.
This demonstrates that the trithioester end groups of polymers might decompose during the deprotection of boc groups in the side chains of polymers under the acidic condition, possibly as a result of hydrolysis although the detailed mechanism of reaction is not clear at this point.
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CPETC + TFA (t = 30 min) Figure S4 . 1 H NMR spectra of CPETC after exposure to TFA
Membrane Depolarization Assay
Cytoplasmic membrane disruption was evaluated for polymers against S. aureus using the membrane potential sensitive dye DISC 3 (5). A single colony of S. aureus was inoculated in MHB for 18h at 37°C, and mid-logarithmic phase cells (OD 600 = 0.5 -0.6) were collected. Cells were then resuspended in buffer (5 mM HEPES, 5 mM sucrose, 100 mM KCl, pH 7.2) to OD 600 = 0.05. A stock solution of DISC 3 (5) in ethanol was added to S. aureus suspension (3 mL). The final dye concentration is 0.5 μM. The cell suspension with DISC 3 (5) (0.5 μM) was stirred at room temperature until the stable reduction in fluorescence intensity was achieved due to quenching upon accumulation of dye on the S. aureus membrane. At 500 s, a solution of polymer (various concentrations, 5 μL) in HEPES buffer was added to the bacterial suspension to give the final concentration (0.5 -8x MIC). The fluorescence intensity was monitored with excitation and emission wavelengths of 622 and 670 nm, respectively. As a control, the changes in fluorescence intensity of dye and polymers mixtures in buffer were determined.
As a control, the changes in fluorescence intensity of DiSC 3 (5) and polymer mixtures in the absence of bacteria were determined ( Figure S5 ). Figure S5 . Fluorescence intensity of DiSC 3 (5) in the presence of AEMP and LPEI. The fluorescence intensity was determined by monitoring the absorbance of dye mixed with polymers in the absence of S. aureus. Dye was added into PBS buffer (final concentration 0.5 μM) and mixed with polymers at their MIC concentrations. A) Shows the dye alone, and mixed separately with LPEI and P 7.7 at their respective MICs. B) Shows the dye mixed with P 7.7 at various concentrations. Open arrows indicate the point of polymer addition. Figure S5 shows the change in absorbance of the dye mixed with polymers in the absence of S. aureus. Both LPEI and P 7.7 caused a decrease in fluorescence at a much faster rate than the dye self-quenches in the absence of bacteria (Fig. S5A) . As the concentration of P 7.7 increased, the rate of fluorescence quenching increased (Fig. S5B ). It is likely that the polymer binds to the dye, and the interaction between the polymer and dye causes quenching of fluorescence from the dye although the molecular mechanism is not clear at this point. (Fig. S5) , the results could be due to the fluorescence quenching by the polymer rather than the inability of polymer to cause membrane depolarization.
Therefore, this approach cannot determine if this lack of substantial change in fluorescence upon introduction of P 7.7 shows that P 7.7 doesn't cause membrane depolarization or if it is a result of fluorescence quenching by the polymer. In addition, a third arrow marks the addition of LPEI, a known membrane depolarizer, for P 7.7 at the MIC and 5x the MIC (Fig. S6B & D) . After the addition of LPEI for P 7.7 at the MIC, the fluorescence increased, indicating that membrane depolarization did occur (Fig. S6B) . However after the addition of LPEI to P 7.7 at 5x the MIC, there is no change in fluorescence (Fig. S6D) . This is likely either because the high concentration of P 7.7 quenches fluorescence caused by the LPEI or P 7.7 in the cell wall prevents membrane depolarization possibly by inhibiting the diffusion of LPEI through the cell wall to the cell membrane. It cannot be ruled out that P 7.7 binds to LPEI, which sequesters the LPEI from solution.
In conclusion, the membrane depolarization assay using DiSC 3 (5) does not provide quantitative results to determine the ability of P 7.7 to cause membrane depolarization in S. aureus due to the strong quenching of fluorescence from DiSC 3 (5) by the polymer.
Cell Leakage Assay
Leakage of UV-absorbing cellular components from S. aureus and E. coli upon treatment with P 7.7 was measured as a measure of membrane disruption by the polymer. The bacteria were regrown in MHB to give an OD 600 > 0.8. The bacterial cells were harvested, and the pellets were washed with PBS. The cells were then resuspended in PBS buffer. Cells were then incubated with the compound of interest (P 7.7 , lysostaphin, melittin, CTAB, or PBS for control) with shaking at 37°C. 2 mL of solution was removed at 2 hours, and centrifuged at 14,000 rpm for 10 minutes to afford cell-free supernatant. The absorbance of cell-free supernatant was measured at 260 and 600 nm. 0.0281 0.0277 CTAB, lysostaphin, melittin, and P 7.7 were tested. PBS buffer without any compound was used as a control. All test compounds were used at a final concentration of at least 3x their MIC in the respective bacteria.
After 2 hours, the assay solution was centrifuged at 14,000 rpm for 10 minutes. The OD 600 values of assay solutions are close to PBS, indicating the supernatant was cell-free after centrifugation. The absorbance of the supernatant was measured at 260 nm to detect UV-absorbing cellular components. As a background, the absorbance of test compounds in PBS without bacteria was determined, and subtracted from the absorbance reading in the presence of bacteria at 260 nm. The corrected absorbance for E. coli and S. aureus are shown in Figure S7 . Figure S7 . UV-absorbing cellular components from S. aureus and E. coli upon treatment with P 7.7 and other controls after 2 hours.
PBS was used as a negative control, as it should cause no leakage of cellular components from the bacterial membrane. CTAB (a cationic surfactant) and melittin (lytic peptide) were used for comparison.
Lysostaphin (an endopeptidase capable of cleaving the crosslinking pentaglycin bridges of Staphylococci for cell lysis) were used as a positive control for 100% leakage for S. aureus. P 7.7 showed a large increase in absorbance at 260 nm for both bacteria after 2 hours of treatment. It appears that P 7.7 causes strong membrane permeabilization. However, the absorbance is significantly higher than the absorbance for lysopstaphin and melittin controls that we expected to give 100% lysis of bacterial cells and subsequent protein leakage.
Therefore, because of the amphiphilic nature of the polymer, P 7.7 is likely to bind to cellular components such as proteins and lipids, which may cause formation of small aggregates. The small aggregates may result in apparent increase in the UV absorbance due to light scattering. The polymer aggregates may also change the environment of UV-sensitive functional groups of proteins, increasing the absorbance.
In conclusion, the membrane permeabilization assay monitoring UV-absorbing cellular components does not provide quantitative results to determine the ability of P 7.7 to cause membrane permeabilization in bacteria due to the increased absorbance, which is likely to reflect the aggregation of cellular components with polymer.
In vivo testing
As a preliminary assessment of the in vivo topical treatment of S. aureus infections using AEMPs, we chose a cotton rat nasal S. aureus colonization model. Two trials were performed: trial 1 involved 5 animals for P 7.7 , 3 animals for mupirocin, and 3 animals for PBS buffer (control); trial 2 involved 5 animals for P 10 , 5 animals for mupirocin, and 5 animals for PBS control. The data from all trials are given below. 
